These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15695344)

  • 1. Highly miniaturized formats for in vitro drug metabolism assays using vivid fluorescent substrates and recombinant human cytochrome P450 enzymes.
    Trubetskoy OV; Gibson JR; Marks BD
    J Biomol Screen; 2005 Feb; 10(1):56-66. PubMed ID: 15695344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate.
    Marks BD; Smith RW; Braun HA; Goossens TA; Christenson M; Ozers MS; Lebakken CS; Trubetskoy OV
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):73-81. PubMed ID: 15090158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening assays for the assessment of CYP2C9*1, CYP2C9*2, and CYP2C9*3 metabolism using fluorogenic Vivid substrates.
    Marks BD; Thompson DV; Goossens TA; Trubetskoy OV
    J Biomol Screen; 2004 Aug; 9(5):439-49. PubMed ID: 15296644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro drug interactions of cytochrome p450: an evaluation of fluorogenic to conventional substrates.
    Cohen LH; Remley MJ; Raunig D; Vaz AD
    Drug Metab Dispos; 2003 Aug; 31(8):1005-15. PubMed ID: 12867489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation.
    Weaver R; Graham KS; Beattie IG; Riley RJ
    Drug Metab Dispos; 2003 Jul; 31(7):955-66. PubMed ID: 12814974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coumarin substrates for cytochrome P450 2D6 fluorescence assays.
    Nakamura K; Hanna IH; Cai H; Nishimura Y; Williams KM; Guengerich FP
    Anal Biochem; 2001 May; 292(2):280-6. PubMed ID: 11355862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a miniaturized 384-well high throughput screen for the detection of substrates of cytochrome P450 2D6 and 3A4 metabolism.
    Kariv I; Fereshteh MP; Oldenburg KR
    J Biomol Screen; 2001 Apr; 6(2):91-9. PubMed ID: 11689103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 (CYP) inhibition screening: comparison of three tests.
    Turpeinen M; Korhonen LE; Tolonen A; Uusitalo J; Juvonen R; Raunio H; Pelkonen O
    Eur J Pharm Sci; 2006 Oct; 29(2):130-8. PubMed ID: 16890411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel laser dye substrate of mammalian cytochromes P450: application in rapid kinetic analysis, inhibitor screening, and directed evolution.
    Kumar S
    J Biomol Screen; 2007 Aug; 12(5):677-82. PubMed ID: 17478480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe.
    Chauret N; Tremblay N; Lackman RL; Gauthier JY; Silva JM; Marois J; Yergey JA; Nicoll-Griffith DA
    Anal Biochem; 1999 Dec; 276(2):215-26. PubMed ID: 10603245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes.
    Linnet K; Olesen OV
    Drug Metab Dispos; 1997 Dec; 25(12):1379-82. PubMed ID: 9394027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
    Shimada T; Mernaugh RL; Guengerich FP
    Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validated assays for human cytochrome P450 activities.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2004 Jun; 32(6):647-60. PubMed ID: 15155557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.
    McLaughlin LA; Dickmann LJ; Wolf CR; Henderson CJ
    Drug Metab Dispos; 2008 Jul; 36(7):1322-31. PubMed ID: 18420780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of coumarin-based fluorogenic P450 BM3 substrates and prospects for competitive inhibition screenings.
    Neufeld K; Zu Berstenhorst SM; Pietruszka J
    Anal Biochem; 2014 Jul; 456():70-81. PubMed ID: 24708937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.